Question follow-through · 111217
IVF: LGBT+ people
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of research from King’s College London, Anglia Ruskin University and the University of Leeds entitled Comparing the Outcom
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 5 Feb 2026
- Target answer date
- 9 Feb 2026
- Answer
- 13 Feb 2026 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Recorded timeline
5 Feb 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of research from King’s College London, Anglia Ruskin University and the University of Leeds entitled Comparing the Outcom
9 Feb 2026
Target answer date
Date supplied by the official written-questions record.
13 Feb 2026
Answer published
The Human Fertilisation and Embryology Authority’s (HFEA) Scientific and Clinical Advances Advisory Committee reviews the published evidence of health outcomes for those having fertility treatment. The last 10 years of evidence were reviewed in June 2025,...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Abortion: Gender
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, if he will make it his policy to require abortion providers to provide clear guidance regarding the legality of procuring a termination on the basis of sex.
Health Services: Statistics
10 Feb 2026 · To ask the Secretary of State for Health and Social Care, if he will have discussions with the Office for National Statistics on revising its back baseline to reflect pre-2020 trends.
Health Services: Transgender People
11 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to support detransitioners.
Gender Dysphoria: Health Services
11 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to implement a data linkage study of the Gender Identity Development Services.
Gender Dysphoria: Children
11 Feb 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his polices on the care of gender distressed children of the US judgment in the case of Fox Varian.
Puberty Suppressing Hormones: Clinical Trials
11 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether he has had discussions with whistleblowers from the former Tavistock Gender Identity Development Service regarding the PATHWAYS Puberty Blocker Trial.
Surrogacy
12 Mar 2026 · To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of the increase in the number of children entering the UK who have been born through surrogacy in countries where commercial surrogacy oper
Surrogacy
12 Mar 2026 · To ask the Secretary of State for Health and Social Care, what information his Department holds on trends in the number of children born via surrogacy abroad, in particular in (a) Kazakhstan and (b) Nigeria.
Surgical Mesh Implants
12 Mar 2026 · To ask the Secretary of State for Health and Social Care, how many patients have reported adverse outcomes following rectopexy mesh procedures in the last ten years; and whether his Department has considered those cases in determining eligibility for mesh
Coronavirus: Vaccination
19 Mar 2026 · To ask the Secretary of State for Health and Social Care, what assessment was made of the potential merits of including an examination of the evidence base relating to the spike protein and lipid nanoparticles used in Covid-19 mRNA vaccines within the sco
Heart Diseases: Yellow Card Scheme
19 Mar 2026 · To ask the Secretary of State for Health and Social Care, what steps the Medicines and Healthcare products Regulatory Agency is taking to improve clinician reporting of myocarditis and pericarditis in the Yellow Card system; and whether the Department has
Medicines and Healthcare products Regulatory Agency: Finance
19 Mar 2026 · To ask the Secretary of State for Health and Social Care, whether the Department has modelled alternative funding structures for the Medicines and Healthcare products Regulatory Agency that would reduce reliance on industry fees; and if it will publish an